Insider · CIK 0001738885

Bodmer Mark

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001738885

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-11-08	Evelo Biosciences, Inc.S Sale	CSO, President of R&D	SSale	−3,163 sh	$0.33	−$1,043.79	25,732
2023-11-07	Evelo Biosciences, Inc.Restricted Stock UnitsM Exercise/Conversion	CSO, President of R&D	MExercise/Conversion	−6,625 sh	—	—	6,625
2023-11-07	Evelo Biosciences, Inc.M Exercise/Conversion	CSO, President of R&D	MExercise/Conversion	+6,625 sh	—	—	28,895
2023-11-02	Evelo Biosciences, Inc.S Sale	CSO, President of R&D	SSale	−6,854 sh	$0.33	−$2,261.82	22,270
2023-11-01	Evelo Biosciences, Inc.M Exercise/Conversion	CSO, President of R&D	MExercise/Conversion	+12.5K sh	—	—	29,124
2023-11-01	Evelo Biosciences, Inc.Restricted Stock UnitsM Exercise/Conversion	CSO, President of R&D	MExercise/Conversion	−12.5K sh	—	—	25,000
2023-09-11	Evelo Biosciences, Inc.Restricted Stock UnitsA Award	CSO, President of R&D	AAward	+37.5K sh	—	—	37,500
2023-08-08	Evelo Biosciences, Inc.S Sale	CSO, President of R&D	SSale	−3,128 sh	$9.51	−$29.7K	16,624
2023-08-07	Evelo Biosciences, Inc.M Exercise/Conversion	CSO, President of R&D	MExercise/Conversion	+6,625 sh	—	—	19,752
2023-08-07	Evelo Biosciences, Inc.Restricted Stock UnitsM Exercise/Conversion	CSO, President of R&D	MExercise/Conversion	−6,625 sh	—	—	13,250
2023-05-23	Evelo Biosciences, Inc.S Sale	CSO, President of R&D	SSale	−22.6K sh	$0.14	−$3,200.568	262,557
2023-05-08	Evelo Biosciences, Inc.S Sale	CSO, President of R&D	SSale	−68K sh	$0.13	−$8,535.757	285,128
2023-05-07	Evelo Biosciences, Inc.M Exercise/Conversion	CSO, President of R&D	MExercise/Conversion	+133K sh	—	—	353,142
2023-05-07	Evelo Biosciences, Inc.Restricted Stock UnitsM Exercise/Conversion	CSO, President of R&D	MExercise/Conversion	−133K sh	—	—	397,500
2023-02-07	Evelo Biosciences, Inc.Restricted Stock UnitsA Award	CSO, President of R&D	AAward	+530K sh	—	—	530,000
2022-01-19	Evelo Biosciences, Inc.Stock Option (Right to Buy)A Award	CSO, President of R&D	AAward	+125K sh	—	—	125,000
2021-01-27	Evelo Biosciences, Inc.Stock Option (Right to Buy)A Award	CSO, President of R&D	AAward	+179K sh	—	—	179,000
2020-01-28	Evelo Biosciences, Inc.Stock Option (Right to Buy)A Award	CSO, President of R&D	AAward	+100K sh	—	—	100,000
2019-01-14	Evelo Biosciences, Inc.Stock Option (Right to Buy)A Award	CSO, President of R&D	AAward	+100K sh	—	—	100,000
2018-05-08	Evelo Biosciences, Inc.Stock OptionA Award	CSO, President of R&D	AAward	+55.4K sh	—	—	55,437

Recent filings

Accepted (ET)
Nov 84
Bodmer Mark0001694665-23-000179
SEC(opens sec.gov)
Nov 34
Bodmer Mark0001694665-23-000169
SEC(opens sec.gov)
Sep 134
Bodmer Mark0001694665-23-000156
SEC(opens sec.gov)
Aug 94
Bodmer Mark0001694665-23-000136
SEC(opens sec.gov)
Jun 124
Bodmer Mark0001694665-23-000080
SEC(opens sec.gov)
May 104
Bodmer Mark0001694665-23-000053
SEC(opens sec.gov)
May 94
Bodmer Mark0001694665-23-000042
SEC(opens sec.gov)
Feb 94
Bodmer Mark0001694665-23-000013
SEC(opens sec.gov)
Jan 214
Bodmer Mark0001694665-22-000015
SEC(opens sec.gov)
Jan 294
Bodmer Mark0001694665-21-000024
SEC(opens sec.gov)
Jan 304
Bodmer Mark0001694665-20-000006
SEC(opens sec.gov)
Jan 164
Bodmer Mark0001694665-19-000006
SEC(opens sec.gov)
May 104
Bodmer Mark0000899243-18-012415
SEC(opens sec.gov)

Companies

Evelo Biosciences, Inc.CSO, President of R&D

Address

620 MEMORIAL DRIVE, SUITE 200

CAMBRIDGE, MA, 02139